BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 25967597)

  • 1. Serum uric acid and the incidence of CKD and hypertension.
    Kuriyama S; Maruyama Y; Nishio S; Takahashi Y; Kidoguchi S; Kobayashi C; Takahashi D; Sugano N; Hosoya T; Yokoo T
    Clin Exp Nephrol; 2015 Dec; 19(6):1127-34. PubMed ID: 25967597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uric acid and incident chronic kidney disease in a large health check-up population in Taiwan.
    Wang S; Shu Z; Tao Q; Yu C; Zhan S; Li L
    Nephrology (Carlton); 2011 Nov; 16(8):767-76. PubMed ID: 21854506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uric acid and incident chronic kidney disease in dyslipidemic individuals.
    Barkas F; Elisaf M; Liberopoulos E; Kalaitzidis R; Liamis G
    Curr Med Res Opin; 2018 Jul; 34(7):1193-1199. PubMed ID: 28836857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of uric acid and left ventricular mass index with renal outcomes in chronic kidney disease.
    Chen SC; Chang JM; Yeh SM; Su HM; Chen HC
    Am J Hypertens; 2013 Feb; 26(2):243-9. PubMed ID: 23382409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uric acid is not associated with decline in renal function or time to renal replacement therapy initiation in a referred cohort of patients with Stage III, IV and V chronic kidney disease.
    Nacak H; van Diepen M; Qureshi AR; Carrero JJ; Stijnen T; Dekker FW; Evans M
    Nephrol Dial Transplant; 2015 Dec; 30(12):2039-45. PubMed ID: 26185050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in uric acid levels and allopurinol use in chronic heart failure: association with improved survival.
    Gotsman I; Keren A; Lotan C; Zwas DR
    J Card Fail; 2012 Sep; 18(9):694-701. PubMed ID: 22939038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High uric acid level is a risk factor for progression of IgA nephropathy with chronic kidney disease stage G3a.
    Moriyama T; Itabashi M; Takei T; Kataoka H; Sato M; Shimizu A; Iwabuchi Y; Nishida M; Uchida K; Nitta K
    J Nephrol; 2015 Aug; 28(4):451-6. PubMed ID: 25355499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of uric acid on kidney function decline differ depending on baseline kidney function in type 2 diabetic patients.
    Hanai K; Tauchi E; Nishiwaki Y; Mori T; Yokoyama Y; Uchigata Y; Babazono T
    Nephrol Dial Transplant; 2019 Aug; 34(8):1328-1335. PubMed ID: 29860523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular calcification in patients with nondialysis CKD over 3 years.
    Górriz JL; Molina P; Cerverón MJ; Vila R; Bover J; Nieto J; Barril G; Martínez-Castelao A; Fernández E; Escudero V; Piñera C; Adragao T; Navarro-Gonzalez JF; Molinero LM; Castro-Alonso C; Pallardó LM; Jamal SA
    Clin J Am Soc Nephrol; 2015 Apr; 10(4):654-66. PubMed ID: 25770175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting Uric Acid and the Inhibition of Progression to End-Stage Renal Disease--A Propensity Score Analysis.
    Uchida S; Chang WX; Ota T; Tamura Y; Shiraishi T; Kumagai T; Shibata S; Fujigaki Y; Hosoyamada M; Kaneko K; Shen ZY; Fujimori S
    PLoS One; 2015; 10(12):e0145506. PubMed ID: 26700005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperuricemia after orthotopic liver transplantation: divergent associations with progression of renal disease, incident end-stage renal disease, and mortality.
    Longenecker JC; Waheed S; Bandak G; Murakami CA; McMahon BA; Gelber AC; Atta MG
    BMC Nephrol; 2017 Mar; 18(1):103. PubMed ID: 28347282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An association between uric acid levels and renal arteriolopathy in chronic kidney disease: a biopsy-based study.
    Kohagura K; Kochi M; Miyagi T; Kinjyo T; Maehara Y; Nagahama K; Sakima A; Iseki K; Ohya Y
    Hypertens Res; 2013 Jan; 36(1):43-9. PubMed ID: 22951520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low HDL cholesterol as a predictor of chronic kidney disease progression: a cross-classification approach and matched cohort analysis.
    Kawachi K; Kataoka H; Manabe S; Mochizuki T; Nitta K
    Heart Vessels; 2019 Sep; 34(9):1440-1455. PubMed ID: 30874893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperuricemia as a Predictive Marker for Progression of Nephrosclerosis: Clinical Assessment of Prognostic Factors in Biopsy-Proven Arterial/Arteriolar Nephrosclerosis.
    Momoki K; Kataoka H; Moriyama T; Mochizuki T; Nitta K
    J Atheroscler Thromb; 2017 Jun; 24(6):630-642. PubMed ID: 27784849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Joint association of hyperuricemia and reduced GFR on cardiovascular morbidity: a historical cohort study based on laboratory and claims data from a national insurance provider.
    Neri L; Rocca Rey LA; Lentine KL; Hinyard LJ; Pinsky B; Xiao H; Dukes J; Schnitzler MA
    Am J Kidney Dis; 2011 Sep; 58(3):398-408. PubMed ID: 21783292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-HDL-cholesterol to HDL-cholesterol ratio as an independent risk factor for the development of chronic kidney disease.
    Zuo PY; Chen XL; Liu YW; Zhang R; He XX; Liu CY
    Nutr Metab Cardiovasc Dis; 2015 Jun; 25(6):582-7. PubMed ID: 25921842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. J-shaped mortality relationship for uric acid in CKD.
    Suliman ME; Johnson RJ; García-López E; Qureshi AR; Molinaei H; Carrero JJ; Heimbürger O; Bárány P; Axelsson J; Lindholm B; Stenvinkel P
    Am J Kidney Dis; 2006 Nov; 48(5):761-71. PubMed ID: 17059995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. U-shaped relationship between serum uric acid level and decline in renal function during a 10-year period in female subjects: BOREAS-CKD2.
    Mori K; Furuhashi M; Tanaka M; Numata K; Hisasue T; Hanawa N; Koyama M; Osanami A; Higashiura Y; Inyaku M; Matsumoto M; Moniwa N; Ohnishi H; Miura T
    Hypertens Res; 2021 Jan; 44(1):107-116. PubMed ID: 32792577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperuricemia has increased the risk of progression of chronic kidney disease: propensity score matching analysis from the KNOW-CKD study.
    Oh TR; Choi HS; Kim CS; Bae EH; Ma SK; Sung SA; Kim YS; Oh KH; Ahn C; Kim SW
    Sci Rep; 2019 Apr; 9(1):6681. PubMed ID: 31040373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated serum homocysteine is a predictor of accelerated decline in renal function and chronic kidney disease: A historical prospective study.
    Levi A; Cohen E; Levi M; Goldberg E; Garty M; Krause I
    Eur J Intern Med; 2014 Dec; 25(10):951-5. PubMed ID: 25457436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.